Clinical trial paradigms and concepts are seemingly evolving, with a clear trend toward the development of regimens rather than single drugs ( 6 ).
← all excerpts
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits.
1
—
—